Session 3.2: Viral Clearance of Emerging Unit Operations: Membrane Chromatography, Other Methods, Etc.

References

1. 1.↵
   1. Stuckey J.,
   2. Strauss D.,
   3. Venkiteshwaran A.,
   4. Gao J.,
   5. Luo W.,
   6. Quertinmont M.,
   7. O'Donnell S.,
   8. Chen D.

   A Novel Approach to Achieving Modular Retrovirus Clearance for a Parvovirus Filter. Biotechnol. Prog. 2014, 30 (1), 79–85.

   OpenUrlCrossRef
2. 2.↵
   1. Venkiteshwaran A.,
   2. Fogle J.,
   3. Patnaik P.,
   4. Kowle R.,
   5. Chen D.

   Mechanistic Evaluation of Virus Clearance by Depth Filtration. Biotechnol. Prog. 2014, 31 (1), 431–437.

   OpenUrl
3. 3.↵
   1. Kang Y. K.,
   2. Hamzik J.,
   3. Felo M.,
   4. Qi B.,
   5. Lee J.,
   6. Ng S.,
   7. Liebisch G.,
   8. Shanehsaz B.,
   9. Singh N.,
   10. Persaud K.,
   11. Ludwig D. L.,
   12. Balderes P.

   Development of a Novel and Efficient Cell Culture Flocculation Process Using a Stimulus Responsive Polymer to Streamline Antibody Purification Processes. Biotechnol. Bioeng. 2013, 110 (11), 2928–2937.

   OpenUrl
4. 4.↵
   1. Liumbruno G. M.,
   2. Marano G.,
   3. Grazzini G.,
   4. Capuzzo E.,
   5. Franchini M.

   Solvent/Detergent-Treated Plasma: A Tale of 30 Years of Experience. Expert Rev. Hematol. 2015, 8 (3), 367–374.

   OpenUrlPubMed
5. 5.↵
   International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Guidance of Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin, Q5A. Federal Register 1998, 63, 51074–51084.

   OpenUrlPubMed
6. 6.↵
   1. Miesegaes G.,
   2. Lute S.,
   3. Brorson K.

   Analysis of Viral Clearance Unit Operations for Monoclonal Antibodies. Biotechnol. Bioeng. 2010, 106 (2), 238–246.

   OpenUrlPubMed
7. 7.↵
   1. Miesegaes G.,
   2. Lute S.,
   3. Reed E.,
   4. Brorson K.

   Viral Clearance by Flow-Through Mode Ion Exchange Columns and Membrane Adsorbers. Biotechnol. Prog. 2014, 14 (1), 124–131.

   OpenUrl
8. 8.↵
   1. Hubbard B.

   Viral Clearance Symposium Session 1.5: Other Viral Clearance and Inactivation Approaches (Multimodal Chromatography, Membrane Chromatography, Chemical Precipitation). PDA J. Pharm. Sci. Technol. 2015, 69 (1), 173–182.

   OpenUrlFREE Full Text
9. 9.↵
   1. Lute S.

   An Update of the FDA Viral Clearance Database. 2015 PDA Virus & TSE Safety Forum, Lisbon, Portugal.
10. 10.↵
    1. Zhou J.,
    2. Tressel T.

    Basic concepts in Q membrane chromatography for large-scale antibody production. Biotechnol. Prog. 2006, 22 (2), 341–349.

    OpenUrlPubMed
11. 11.↵
    PDA Technical Report No. 47. Parenteral Drug Association: Bethesda, MD, 2010.